NASDAQ:CCCC | Profit Breakdown | C4 Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-09-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$6.64M-$26.42M-$23.64M
2026-03-31$6.15M-$27.79M-$25.13M
2025-12-31$11.02M-$23.15M-$20.37M-$20.49M
2025-09-30$11.23M-$34.41M-$32.17M-$32.17M
2025-06-30$6.46M-$28.5M-$26.02M-$26.02M
2025-03-31$7.24M-$29.16M-$26.32M-$26.32M
2024-12-31$5.18M-$37.71M-$34.44M-$34.57M
2024-09-30$15.36M-$28.24M-$24.67M-$24.67M
2024-06-30$12.01M-$21.44M-$17.72M-$17.72M
2024-03-31$3.04M-$32.22M-$28.36M-$28.36M
2023-12-31$3.26M-$37.43M-$34.48M-$34.75M
2023-09-30$11.07M-$27.81M-$26.03M-$27.04M
2023-06-30$2.66M-$37.57M-$35.92M-$35.92M
2023-03-31$3.76M-$36.23M-$34.78M-$34.78M
2022-12-31$2.85M-$38.29M-$37.19M-$37.19M
2022-09-30$6.75M-$32.49M-$31.96M-$31.96M
2022-06-30$13.83M-$27.38M-$27.41M
2022-03-31$7.65M-$31.37M-$31.62M-$31.62M
2021-12-31$20.08M-$15.26M-$15.66M-$15.66M
2021-09-30$8.5M-$24.25M-$24.68M-$24.68M
2021-06-30$9.78M-$22.12M-$22.58M-$22.58M
2021-03-31-$20.51M-$20.97M-$20.97M
2020-12-31-$18.9M-$21.92M-$21.8M
2020-09-30-$18.35M-$22M-$21.84M
2020-06-30-$10.86M-$10.96M-$10.79M
2020-03-31-$12.34M-$12.08M-$11.91M
2019-12-31-$10.5M-$10.12M-$10.02M
2019-09-30-$10M-$9.44M-$10.09M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$35.95M-$115.22M-$104.87M-$104.99M
2024-12-31$35.58M-$119.61M-$105.19M-$105.32M
2023-12-31$20.76M-$139.03M-$131.21M-$132.49M
2022-12-31$31.1M-$129.53M-$128.18M-$128.18M
2021-12-31$45.79M-$82.13M-$83.89M-$83.89M
2020-12-31-$60.45M-$66.96M-$66.34M
2019-12-31-$35.45M-$33.3M-$34.1M